Skip to main content

Table 3 Outcomes of patients with stage I seminoma

From: Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy

 

Radiation (n = 56)

Surveillance (n = 61)

P value

Follow–up months

  

<0.01

  mean ± SD (range)

174 ± 54 (16–339)

67 ± 50 (5–257)

Era n (%)

  

<0.001

  1980s

12 (80.0%)

3 (20.0%)

  1990s

42 (91.3%)

4 (8.7%)

  2000s

2 (3.5%)

54 (94.7%)

Relapse

  

0.19

  n (%)

1 (1.7%)

4 (6.6%)

  Site

chest wall 1

lymph-node 4

  

liver 1

  Time to relapse

16 months

5–7 (mean 7)

Treatment after relapse

  

0.99

  Chemotherapy

1 (100%)

4 (100%)

  Radiation

0 (0%)

1 (25%)

Prognosis

   

  Cause-specific death

0 (0%)

0 (0%)

0.99

  Death of other causes

4 (7.1%)

1 (1.6%)

0.13

  1. One patient receiving adjuvant chemotherapy was excluded.
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us